New Body Mass Index (BMI) Cut-offs for the Diagnosis of Obesity and Comorbidities
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01055626|
Recruitment Status : Unknown
Verified October 2016 by Gema Frühbeck Martínez, Clinica Universidad de Navarra, Universidad de Navarra.
Recruitment status was: Recruiting
First Posted : January 25, 2010
Last Update Posted : October 26, 2016
|Condition or disease|
|Obesity Overweight Diabetes Mellitus, Type 2|
|Study Type :||Observational|
|Estimated Enrollment :||6000 participants|
|Official Title:||Usefulness of the Determination of Body Composition for Establishing New Cut-offs for the Diagnosis and Follow-up of Obesity and Comorbidities|
|Study Start Date :||January 2005|
|Estimated Primary Completion Date :||December 2016|
|Estimated Study Completion Date :||December 2017|
- Differences in body fat [ Time Frame: Baseline ]For classically defined BMI categories (normalweight, overweight and obesity) body fat will be assessed by air-displacement plethysmography (Bod-Pod)
- Differences in glycemic control [ Time Frame: Baseline ]For classically-defined BMI categories measurement of fasting plasma glucose, insulin HOMA as well as response to OGTT will be related to actual body adiposity.
- Differences in cardiovascular risk factors [ Time Frame: Baseline ]For classically-defined BMI categories measurement of circulating total cholesterol, LDL-cholesterol, HDL-cholesterol, fibrinogen, C-reactive protein, homocysteine, von Willebrand factor and adipokines will be related to actual body adiposity.
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01055626
|Contact: Gema Frühbeck, MD, PhD||34 948255400 ext firstname.lastname@example.org|
|Clinica Universidad de Navarra - University of Navarra||Recruiting|
|Pamplona, Navarra, Spain, 31008|
|Contact: Gema Frühbeck, MD, PhD 34 948255400 ext 4484 email@example.com|
|Sub-Investigator: Javier Gómez-Ambrosi, PhD|
|Clinica Universidad de Navarra||Enrolling by invitation|
|Principal Investigator:||Gema Frühbeck, MD, PhD||Clínica Universidad de Navarra|